| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |